|
C7ORF59 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.633600E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.649600E-02 |
| Normal-vs-Stage2 |
7.315600E-01 |
| Normal-vs-Stage3 |
1.675600E-01 |
| Normal-vs-Stage4 |
1.915200E-03 |
| Stage1-vs-Stage2 |
9.212300E-02 |
| Stage1-vs-Stage3 |
5.999000E-01 |
| Stage1-vs-Stage4 |
5.230200E-02 |
| Stage2-vs-Stage3 |
1.797450E-01 |
| Stage2-vs-Stage4 |
1.416320E-02 |
| Stage3-vs-Stage4 |
5.212000E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.412100E-02 |
| Normal-vs-AfricanAmerican |
5.333900E-02 |
| Normal-vs-Asian |
5.022400E-02 |
| Caucasian-vs-AfricanAmerican |
3.469800E-01 |
| Caucasian-vs-Asian |
5.600000E-01 |
| AfricanAmerican-vs-Asian |
6.726000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.559600E-02 |
| Normal-vs-Female |
1.097220E-01 |
| Male-vs-Female |
5.203000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.608400E-02 |
| Normal-vs-Age(41-60Yrs) |
1.127780E-01 |
| Normal-vs-Age(61-80Yrs) |
1.775250E-01 |
| Normal-vs-Age(81-100Yrs) |
8.360400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.726000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.285200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.568600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.122600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.332400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.549400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.295200E-01 |
| Classical-VS-Follicular |
5.599400E-04 |
| Classical-VS-Other |
9.912000E-01 |
| Classical-VS-Normal |
1.275800E-02 |
| Tall-VS-Follicular |
1.846190E-02 |
| Tall-VS-Other |
6.308600E-01 |
| Tall-VS-Normal |
4.547700E-02 |
| Follicular-VS-Other |
1.851850E-02 |
| Follicular-VS-Normal |
7.946400E-01 |
| Other-VS-Normal |
5.106100E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.164800E-01 |
| Normal-vs-N1 |
9.743700E-02 |
| N0-vs-N1 |
1.185570E-01 |
|
|
